| |
|
| |
Ovarian
Aging and Infertility
Jane
L. Frederick, MD, FACOG
Board Certified, Reproductive
Endocrinology and Infertility |
|

The
decrease in female fecundity beginning after the age
of 30 and exaggerated after 40, is a well documented
finding. This age
related decline in fertility is the result of several
factors that contribute to overall reproductive failure.
Women over 35 require a longer period to achieve conception
than younger individuals, and a higher percentage of
older than younger women will never achieve pregnancy.
In addition, the rate of early pregnancy wastage increases
substantially during
the 30s, and is over 50% after age 40.
With
the aging of the baby boom generation and social trends
to delay childbearing, the treatment of women ³
40 years of age who desire fertility has become a major
challenge of today's fertility specialists. For many
women, the option to exercise other choices while deferring
their reproduction, has resulted in the need to use
new reproductive technologies while treating their infertility.
These technologies include controlled ovarian
hyperstimulation (COH),
intrauterine insemination (IUI), and assisted reproductive
techniques such as IVF and the use of donor eggs. Though the age related decline in pregnancy is seen
in ART, there are few reports of COH-IUI results with
respect to age. I would like to share my report of a
large series of COH-IUI in women 40 years and older.
RESULTS OF IUI
IN PATIENTS > 40
Table
I (see below) shows the pregnancy rates of COH-IUI
with respect to age of the patient. In the patients
who were ³ 40 years of age, a total of 300 cycles
were initiated, of which 30% were canceled due to poor
response. Of the remaining 210 cycles, there was an
average of 2.7 cycles per patient. The average number
of follicles per cycle with COH was 5.3 + 3.0. The type
of COH protocol used, or whether hCG was administered,
did not affect cycle outcome. A total of 11 pregnancies
were achieved, with 8 spontaneous abortions, giving
a live birth rate of 3.8% per patient and 1.4% per cycle.
This is in sharp contrast to the pregnancy rates in
patients less than 39 years old receiving IUI and identical
protocols of ovarian stimulation. Out of 543 patients,
there were 141 pregnancies for a pregnancy rate of 21%
per patient and 10% per cycle. Miscarriage rate in this
group was 18% (Human Reproduction, 9:2284-86, 1994).
LITERATURE REVIEW
Over
the past 15 years, there has been a surge in the assisted
reproductive technologies available to treat infertility.
Given such a vast array of treatments, clinicians are
faced with uncertainty about the optimal technique for
an individual patient with functional fallopian tubes.
The optimal choice depends on the IVF
success rates per cycle (cycle fecundity) and costs,
as well as the degree of invasiveness associated with
each of these procedures. Recently, some authors have
suggested superovulation with hMG, combined with IUI
as an alternative treatment for couples with non tubal
causes of infertility.
--------------------------------------------------------------------------------
Table I- Pregnancy Rates with Intrauterine
Insemination (IUI)
|
<
39 Years Old |
<
40 Years Old |
| Patients |
543 |
77 |
| Cycles |
1198 |
210 |
| Cycles/Patient |
2.2 |
2.7 |
| Pregnancies |
141 |
11 |
| Pregnancy
rate/patient |
26% |
14% |
| Pregnancy
rate/cycle |
12% |
5% |
| Miscarriage
rate |
25
(18%) |
8
(72%) |
| Live
Birth Rate/Patient |
21% |
3.8% |
| Live
Birth Rate/cycle |
10% |
1.44% |
--------------------------------------------------------------------------------
A review of the literature
dealing with IUI by Allen et
al evaluated the results in 18 studies with a 28% mean
pregnancy rate (range 3.4% - 62%) in 714 patients. Confounding
variables including specifics of sperm preparation,
reason for IUI, insemination timing, and number of attempts
per cycle and few studies reported on the efficacy of
IUI with respect to age of the patient. Further studies
by Dodson et al showed that the mean serum estradiol
concentration per follicle is inversely proportional
to age, and that the woman's age is inversely proportional
to cycle fecundity with IUI. My results show there is
a very poor live birth rate (1.4%) per cycle in infertile
couples in which the female partner is ³ 40 years
of age and treated with COH/ IUI. This study seriously
questions the indication of COH and IUI in women ³
40 years old.
SPONTANEOUS
ABORTION RATE
The incidence of miscarriage
rises markedly with maternal age. Cytogenetic studies
have shown that in 40% of all first trimester abortions,
there is evidence of chromosomal abnormalities, and
the majority of these anomalies are autosomal trisomic
defects. Among recognized conceptions there is an exponential
rise in the frequency of trisomies of almost every human
chromosome with advancing maternal age.
IVF
The early use of IVF in the treatment of women over 40 was influenced by
the experience of Steptoe and Edwards, who reported
a pregnancy rate less than half of that for women under
40 along with a spontaneous abortion rate that was almost
60%, yielding a live birth rate of only 3%.
The most recently published
data from the US IVF-ET registry mimics the early Bourne
Hall experience. The results of 5,868 IVF cycles from
281 clinics in 1995 where a delivered pregnancy rate
for women 40 or older was 8% compared with 19% for all
age groups. The older women also suffered a 36% spontaneous
abortion rate. Previous data from 5,590 cycles collected
from 48 French IVF centers in 1986 demonstrated a marked
reduction in both oocyte production and embryo implantation
beginning at age 37, that lowered the pregnancy rate
from 19.8% in women under 25 to 9% in women over 40.
Older women undergoing IVF have high cancellation rates,
most often because of insufficient follicular development,
but the pregnancy rate declines with increasing age
regardless of the number of embryos transferred. Many of these women opt to enter our donor egg program.
LEADING
FACTORS
Biological data suggest
at least three factors undergo change: at age 37, the
uterus becomes increasingly unreceptive to maintaining
pregnancy; oocyte abnormalities, most commonly expressed
as chromosomal trisomies, finally become clinically
dominant and compose half of all conceptions after 45;
and altered patterns of gonadotropin release, marked
by rising basal FSH levels, increase incidence of irregular
menstrual function, which finally expresses itself as
the inability to conceive.
It is biologic or ovarian
age and not chronologic age that most likely determines
the endpoint of fertility. Women who conceive late in
life generally have a late menopause and the number
of years from the loss of fertility to menopause appears
to be about 10 years. As there is no accurate way to
predict the onset a decade in advance, perhaps women
have been right all along when they say they hear their
ticking of their biologic clocks.
IMPACT
OF EGG DONATION 
Egg
donation dramatically alters the fertility
of women over 40. Success rates are independent
of age. Most series reports now demonstrate live birth
rates above 30% per embryo transfer in patients up to
55. Lifetable analysis indicates that more than half
of perimenopausal women will be successful within three
attempts of oocyte donation, and more than 85% by the
fifth try. Furthermore, miscarriage rates reflect that
of the donor, who is usually under 35. Thus, losses
are experienced typically in fewer than 15% of conditions
(See Figure I below). See our donor egg program success rates.
Maternal age decreases
liveborn rates after assisted reproductive technology
(ART). These data are from the 45,906 fresh ART cycles
with patients' own oocytes reported to the Society for
Assisted Reproductive Technology and the Centers for
Disease Control and Prevention for the year 1995. Advancing
maternal age adversely affects live birth rates following
ART. When fresh donor ART cycles are plotted, pregnancy
rates do not decrease even into the 40s.
Adapted from SART/CDQ
report for ART clinics, 1995, December, 1997.
Results of oocyte
( egg ) donation programas suggests that although the uterus
is less relative in women over 40, it is the ability
of the aging oocyte that is the most important factor
in the decreasing fertility of older women. Patients
have indicated satisfaction after having made the decision
to proceed with oocyte donation. Only time will tell
if this trend becomes the accepted norm.
FIGURE
I- Live births per transfer for fresh embryos
from own and donor eggs, by age of recipient, 1995.
Additional Age and Infertility Articles
|